Cardiometabolic Health Congress | Agenda | CME Conference Schedule, Symposia, Keynote Session, Presentations

Home

•

Site Map

•

Useful Links

October 10-13, 2012 · Westin Boston Waterfront · Boston, MA

Join Our Mailing List

2011 Congress Details

2010 Congress Details

2009 Congress Details

2008 Congress Details

2007 Congress Details

2006 Congress Details

2011 Online CME Activity

Useful Links

Recommend This Site

Download 2012 Preliminary Brochure

2011 Program Agenda

Wednesday Thursday Friday Saturday

Join our mailing list to receive the latest updates.

Wednesday, October 19, 2011
2:00pm – 3:30pm	Afternoon Symposium Optimal Strategies for Primary & Secondary Prevention of ACS in Patients with T2DM: Clinical Dilemmas, Expert Recommendations & Future Directions for Global CV Risk Reduction Supported by an educational grant from Genentech, Inc.	Christopher Cannon, MD Darren McGuire, MD Stephen Nicholls, MD Jorge Plutzky, MD
4:00pm – 5:30pm	ACCF Afternoon Symposium Culture, Language, and Diabetes: Strategies for Reducing CVD Among Your Highest Risk Patients Sponsored by the American College of Cardiology Foundation and Co-sponsored by the Coalition to Reduce Disparities in CV Outcomes, National Alliance for Hispanic Health, National Committee for Quality Assurance and The Endocrine Society This activity is supported by educational grants provided by Abbott, Genentech, Lilly, Merck, and sanofi-aventis	Rhonda Bentley-Lewis, MD Keith Ferdinand, MD Robert Like, MD
6:00pm – 8:00pm	Dinner Symposium The Future of T2DM Management: Addressing Disease Pathophysiology and Targeting Global Cardiometabolic Risk Supported by an educational grant from Amylin Pharmaceuticals, Inc. and Lilly USA, LLC	David Aguilar, MD John Buse, MD Anne Peters, MD Carol Wysham, MD

Thursday, October 20, 2011
6:15am – 8:00am	Breakfast Symposium A Advances in Basal Insulin: Addressing the Barriers to Initiation and Intensification of Diabetes Therapy Supported by an educational grant from Novo Nordisk, Inc.	Martin Abrahamson, MD Luigi Meneghini, MD Bernard Zinman, MD
6:15am – 8:00am	Breakfast Symposium B Overcoming Today’s Top Challenges to Effective Screening, Diagnosis, and Management of Patients with Severe or Familial Hypercholesterolemia: Expert Recommendations & Interactive Case Review Supported by an educational grant from Genzyme	Christie Ballantyne, MD William Cromwell, MD Mary P. McGowan, MD Jean-Claude Tardif, MD
8:00am – 8:05am	Opening Remarks	Jay Skyler, MD
8:05am – 8:45am	Keynote Session Inflammation: The Fire That Encircles Dysmetabolism & Cardiovascular Disease	Peter Libby, MD
8:45am – 9:30am	Keynote Session Insulin Resistance, Obesity, and Type 2 Diabetes	C. Ronald Kahn, MD
9:30am - 10:00am	T2DM 2011: Physiologic Heterogeneity & the Monotherapy Paradox	James Gavin III, MD
10:00am – 10:45am	Morning Break/Exhibit Hall
10:45am - 11:15am	T2DM 2011: Re-thinking Treatment Algorithms	John Buse, MD
11:15am - 12:15pm	T2DM 2011: Clinical Controversies & Expert Recommendations for Optimal Patient Care	moderator: Jay Skyler, MD panelists: John Buse, MD James Gavin III, MD Darren McGuire, MD
12:30pm – 2:00pm	Lunch Symposium A New Paradigms for Targeting A1C and Global Cardiometabolic Risk: Expert Recommendations for Optimizing GLP-1 Analogs in the T2DM Continuum of Care Supported by an educational grant from Novo Nordisk, Inc.	John Buse, MD Vivian Fonseca, MD Edward Horton, MD Bernard Zinman, MD
12:30pm – 2:00pm	Lunch Symposium B Antiplatelet Therapy 2011: Clinical Challenges & Expert Recommendations for State-of-the-Art Treatment of Patients with ACS Undergoing PCI Supported by an educational grant from Daiichi Sankyo, Inc. and Eli Lilly and Company	Christopher Cannon, MD Paul Gurbel, MD Neal Kleiman, MD Marc Sabatine, MD
2:15pm – 2:45pm	Keynote Session Leptin and the Regulation of Energy Balance: A Framework for New Therapies for Obesity	Jeffrey Friedman, MD
2:45pm – 3:15pm	Obesity and Non-Alcoholic Fatty Liver Disease: The Cirrhosis Epidemic of Our Time?	Samuel Klein, MD
3:15pm – 3:45pm	Afternoon Break/Exhibit Hall
3:45pm – 4:15pm	Obesity: Why Is Weight Loss So Hard to Sustain?	Robert Eckel, MD
4:15pm – 4:45pm	Medical vs. Surgical Management of Obesity: Metabolic Mechanisms of Weight Loss After Bariatric Surgery	Lee M. Kaplan, MD
4:45pm – 5:15pm	Obesity Panel Discussion	moderator: Robert Eckel, MD panelists: Jeffrey Friedman, MD Lee M. Kaplan, MD Samuel Klein, MD
5:15pm	Closing Remarks	Robert Eckel, MD
5:15pm – 6:15pm	Welcome Reception
6:30pm – 8:30pm	Dinner Symposium A New Pathway Ahead: Targeting the Kidney in the Management of Patients with T2DM Supported by an educational grant from Bristol-Myers Squibb and AstraZeneca LP	George Bakris, MD Jaime Davidson, MD Vivian Fonseca, MD Mark Molitch, MD

Friday, October 21, 2011
6:15am – 8:00am	Breakfast Symposium A Stable Ischemic Heart Disease 2011: Appreciating the Impact of Patient Variations and Comorbidities on Clinical Decision Making Supported by an independent educational grant from Gilead Sciences Medical Affairs	Christopher Cannon, MD Puja Mehta, MD David A. Morrow, MD Eric Velazquez, MD
6:15am – 8:00am	Breakfast Symposium B Vasodilating Beta Blockers: A New Generation of Options for Targeting Endothelial Dysfunction, Hypertension and Global CV Risk Supported by an educational grant from Forest Laboratories, Inc.	George Bakris, MD Thomas Giles, MD Alan Gradman, MD R. Preston Mason, PhD
8:00am – 8:05am	Opening Remarks	Christie Ballantyne, MD
8:05am – 8:45am	Keynote Session Translating Human Genetics into Novel Therapies for Dyslipidemia & Atherosclerosis	Daniel Rader, MD
8:45am – 10:00am	Late-Breaking Clinical Trials & FDA Update	moderator:Christie Ballantyne, MD panelists: Christopher Cannon, MD Robert Eckel, MD Keith Ferdinand, MD Jay Skyler, MD
10:00am – 10:45am	Morning Break/Exhibit Hall
10:45am – 11:45am	Hot Topics in Lipid Management: Debate & Case-Based Discussion Beyond LDL: Is “Advanced” Lipid Testing Useful? Should We Treat Lp(a)? High-Dose Statin vs. Combination Therapy	moderator: Christie Ballantyne, MD panelists: Michael Davidson, MD Robert Eckel, MD JoAnne Foody, MD
12:00pm - 1:30pm	Lunch Symposium A Statin Therapy in Clinically Complex Patients: Expert Recommendations and Evidence-Based Strategies for Achieving Optimal Results Supported by an educational grant from Kowa Pharmaceuticals America, Inc. and Lilly USA, LLC	Christie Ballantyne, MD Eliot Brinton, MD Tara Dall, MD Michael Davidson, MD
12:00pm - 1:30pm	Lunch Symposium B A RAAS Based Approach to Blood Pressure Management in Hypertensive Patients, including those with Diabetes Sponsored by Novartis Pharmaceuticals Corporation	Gerald Appel, MD
1:45pm – 2:45pm	Hot Topics in Lipid Management: Debate & Case-Based Discussion (continued) Do We Need to Raise HDL? Should We Treat High Triglycerides?	moderator: Christie Ballantyne, MD panelists:Michael Davidson, MD Robert Eckel, MD JoAnne Foody, MD
2:45pm – 3:15pm	Afternoon Break/Exhibit Hall
3:15pm – 3:45pm	Lipids, the Kidney, & CVD: Expert Analysis	George Bakris, MD
3:45pm – 5:00pm	Updates in Hypertension Guidelines & Controversies Starting with Combo Therapy CKD – Is It a MI Equivalent? Microalbuminuria as a CV Marker? Heart Rate and CV Outcomes with HTN	moderator: George Bakris, MD panelists: Brad Astor, PhD William Cushman, MD Richard Glassock, MD Alan Gradman, MD
5:00pm	Closing Remarks	George Bakris, MD
6:00pm – 8:00pm	Dinner Symposium Targeting Triglycerides: Current Challenges and Emerging Options for Cardiovascular Risk Reduction Supported by an educational grant from Amarin Corporation	Christie Ballantyne, MD Harold Bays, MD R. Preston Mason, PhD Michael Miller, MD

Saturday, October 22, 2011
6:15am – 8:00am	Breakfast Symposium Early Diagnosis and Treatment of PAH: Evidence-Based Strategies and Expert Recommendations for Improving Patient Outcomes Supported by an educational grant from Actelion Pharmaceuticals US, Inc.	David Badesch, MD Paul Forfia, MD Richard Channick, MD
8:00am – 8:05am	Opening Remarks	Christie Ballantyne, MD
8:05am – 9:30am	Emerging Biomarkers vs. Imaging for Cardiometabolic Risk Assessment	moderator: Christie Ballantyne, MD panelists: Matthew Budoff, MD James de Lemos, MD Pamela Douglas, MD Paul Ridker, MD
9:30am – 10:30am	Hot Topics in Thrombosis and ACS	moderator: Deepak Bhatt, MD panelists: C. Michael Gibson, MD E. Magnus Ohman, MD
10:30am – 10:45am	Morning Break
10:45am - 11:30am	Hormone Replacement Therapy & Cardiometabolic Risk	moderator: Robert Eckel, MD panelists: Shalender Bhasin, MD Margaret Wierman, MD
11:30am – 12:15pm	Sleep Apnea and Cardiometabolic Risk	Francisco Lopez-Jimenez, MD
12:15pm	Closing Remarks	Robert Eckel, MD

Dyslipidemia Conference • Hypertension Conference • Type 2 Diabetes Conference • Insulin Resistance Conference • Obesity Conference